Evidence for intact 5-HT1A receptor-mediated feedback inhibition following sustained antidepressant treatment in a rat model of depression

Neuropharmacology
Jessica A BabbKathryn G Commons

Abstract

Serotonin (5-HT) neurons are strongly implicated in mood disorders such as depression and are importantly regulated by feedback inhibition mediated by 5-HT1A receptors. These receptors may play a role, albeit a poorly understood one, in the generation of mood disorders, treatment response to antidepressants and delayed therapeutic efficacy. Here we sought to gain insight into the role of 5-HT1A receptor-mediated feedback inhibition in these processes by studying Fos protein expression within serotonin neurons in a rat model of stress-related mood disorder, early life maternal separation (MS), combined with two-week treatment with the antidepressant fluoxetine (FLX) in adulthood. We gauged 5-HT1A receptor-mediated feedback inhibition by the ability of the antagonist, WAY-100635 (WAY), to disinhibit Fos expression in 5-HT neurons. We found that two-week FLX treatment dramatically inhibited Fos expression in serotonin neurons and that this effect was reversed by blocking 5-HT1A receptors with WAY. Together these observations reveal that after prolonged exposure to SSRIs, endogenous 5-HT1A receptors continue to exert feedback inhibition of serotonin neurons. Furthermore we found unique effects of pharmacological treatments after MS...Continue Reading

References

Jul 1, 1994·Trends in Pharmacological Sciences·P Blier, C de Montigny
Dec 22, 1999·Neuroreport·L LanfumeyC Cohen-Salmon
Aug 30, 2000·Nuclear Medicine and Biology·W C DrevetsC Mathis
May 28, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paul M PlotskyMichael J Meaney
Aug 18, 2006·Psychopharmacology·Benjamin R ChemelDavid E Nichols
Jun 19, 2007·Journal of Psychiatric Research·Maura BoldriniVictoria Arango
Oct 9, 2007·Nuclear Medicine and Biology·Wayne C DrevetsChester Mathis
Jan 17, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Francis Rodriguez BambicoGabriella Gobbi
May 12, 2009·Progress in Neurobiology·Jonathan SavitzWayne C Drevets
May 31, 2011·Molecular Brain·Paul R AlbertAnne M Millar
Oct 7, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Robert R RozeskeSteven F Maier
Jun 14, 2012·Neurobiology of Disease·Jonathan B Savitz, Wayne C Drevets
Jan 22, 2013·ACS Chemical Neuroscience·Stefanie C AltieriAnne M Andrews
Jan 8, 2016·Brain Structure & Function·Kathryn G Commons
May 27, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Reka NatarajanBryan K Yamamoto

❮ Previous
Next ❯

Citations

Jan 3, 2020·Behavioural Pharmacology·Shengying PanHaiyan He
Jun 10, 2020·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Graziele Freitas de BemAngela Castro Resende
Feb 2, 2021·The FEBS Journal·Praachi TiwariVidita A Vaidya
Feb 27, 2019·ACS Chemical Neuroscience·Kathryn G Commons, Sofia E Linnros

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.